Testing effectiveness (Phase 2)Study completedNCT06358950
What this trial is testing
Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)
Who this might be right for
Narcolepsy Type 1
Alkermes, Inc. 92